









Markets
/
Stocks
/
nasdaq-usna
/

USANA Health Sciences Inc

USNA

19.130USD

-0.030-0.16%

Close 11/07, 16:00（ET）Quotes delayed by 15 min

349.54MMarket Cap

20.57P/E TTM



USANA Health Sciences Inc

19.130

-0.030-0.16%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of USANA Health Sciences Inc

Currency: USD Updated: 2025-11-07

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a . Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

USANA Health Sciences Inc's Score

Industry at a Glance

Industry Ranking

69 / 96

Overall Ranking

356 / 4614

Industry

Food & Tobacco

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

39.000

Target Price

+103.55%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

USANA Health Sciences Inc Highlights

StrengthsRisks

USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. The Company operates through one segment: Direct-selling. Its two geographic regions include Asia Pacific, and Americas and Europe. The Company’s product lines include USANA Nutritionals Optimizers, Essentials/CellSentials, foods, personal care, skin care, and all others. The USANA Nutritionals Optimizers consist of supplements designed to meet individual health and nutritional needs. The Essentials/CellSentials product line includes vitamin and mineral supplements that provide total body nutrition. Its food product line includes meal replacement shakes, snack bars, and other related products. It also offers products designed for prenatal, infant, and young-child age groups in China. It distributes products internationally through direct selling, which entails person-to-person marketing and selling of products.

Overvalued

The company’s latest PE is 21.09, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 11.23M shares, decreasing 4.57% quarter-over-quarter.

Held by Richard Pzena

Star Investor Richard Pzena holds 1.21M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.10.

Financial Health

Currency: USD Updated: 2025-11-07

The company's current financial score is 7.32, which is higher than the Food & Tobacco industry's average of 7.08. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 213.67M, representing a year-over-year increase of 6.72%, while its net profit experienced a year-over-year increase of 161.49%.

Score

Industry at a Glance

Previous score

7.32

Change



Financials

7.29

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.51

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.25

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.28

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.26

Key Metrics

Free cash flow

No Data

USANA Health Sciences Inc's Company Valuation

Currency: USD Updated: 2025-11-07

The company’s current valuation score is 8.78, which is higher than the Food & Tobacco industry's average of 7.47. Its current P/E ratio is 21.09, which is 44.12% below the recent high of 30.40 and 44.31% above the recent low of 11.75.

Score

Industry at a Glance

Previous score

8.78

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 69/96

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-07

There is no earnings forecast score for this company; the Food & Tobacco industry's average is 7.37. The average price target for USANA Health Sciences Inc is 39.00, with a high of 39.00 and a low of 39.00.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-07

The company’s current price momentum score is 6.07, which is lower than the Food & Tobacco industry's average of 6.92. Sideways: Currently, the stock price is trading between the resistance level at 20.92 and the support level at 18.02, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.37

Change

-0.3

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(5)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.380

Neutral

RSI(14)

29.198

Sell

STOCH(KDJ)(9,3,3)

19.918

Sell

ATR(14)

0.944

High Vlolatility

CCI(14)

-160.881

Sell

Williams %R

85.026

Oversold

TRIX(12,20)

-1.073

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

20.100

Sell

MA10

20.143

Sell

MA20

20.484

Sell

MA50

25.601

Sell

MA100

28.322

Sell

MA200

28.814

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-07

The company’s current institutional recognition score is 5.00, which is lower than the Food & Tobacco industry's average of 5.55. The latest institutional shareholding proportion is 61.48%, representing a quarter-over-quarter decrease of 40.01%. The largest institutional shareholder is Richard Pzena, holding a total of 1.21M shares, representing 6.64% of shares outstanding, with 16.35% increase in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Gull Global, Ltd.

7.74M

-1.81%

BlackRock Institutional Trust Company, N.A.

1.54M

-4.82%

Pzena Investment Management, LLC

Star Investors

1.20M

+9.41%

Renaissance Technologies LLC

Star Investors

1.15M

+6.41%

The Vanguard Group, Inc.

Star Investors

989.78K

-26.79%

Dimensional Fund Advisors, L.P.

897.73K

+5.41%

State Street Investment Management (US)

426.34K

-5.54%

Jacobs Levy Equity Management, Inc.

350.61K

+85.99%

Geode Capital Management, L.L.C.

310.52K

-3.04%

American Century Investment Management, Inc.

255.03K

-0.08%

Risk Assessment

Currency: USD Updated: 2025-11-07

The company’s current risk assessment score is 3.94, which is lower than the Food & Tobacco industry's average of 5.44. The company's beta value is 0.66. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.